Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 86,560 |
| Marketable Securities | 97,810 |
| Receivables | 13,530 |
| Inventories | 330 |
| Other current assets | 186,840 |
| TOTAL | $385,070 |
| Non-Current Assets | |
| Other Non-Current Assets | 80,460 |
| TOTAL | $80,460 |
| Total Assets | $469,520 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 50,650 |
| Other current liabilities | 3,260 |
| TOTAL | $53,910 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 1,010 |
| TOTAL | $10,180 |
| Total Liabilities | $64,110 |
| Shareholders' Equity | |
| Common Shares | 33,250 |
| Retained earnings | -110,060 |
| Other shareholders' equity | -490 |
| TOTAL | $405,400 |
| Total Liabilities And Equity | $469,510 |